Diabetes Epidemiology in the COVID-19 Pandemic.
Where this comes from
- Record sourced from PubMed, PMID 32540920.
- Also identified by DOI 10.2337/dc20-1295 and PMC identifier 7372044.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comorbidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Diabetes Mellitus
- Pandemics
- Pneumonia, Viral